![]() |
|
|
Molecular Pharmacology, Vol 19, 444-450, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
-Hydroxylase
1 Departments of Medicine, Veterans Administration Medical Center and the University of California, San Diego, California
92161
A homologous radioimmunoassay for human plasma dopamine-
-hydroxylase (DBH) is
described. An antiserum specific for the purified plasma enzyme was found to cross-react
fully with soluble DBH isolated from human pheochromocytoma and normal adrenal
medulla. Similarly, an assay developed using pheochromocytoma DBH as an antigen
gave equivalent results, and the two methods were interchangeable for the determination
of immunoreactive DBH in human plasma. Bovine adrenal medullary DBH, on the other
hand, cross-reacted poorly in these assays. The homospecific activity of DBH in pooled,
normal human plasma, expressed as units of enzymatic activity per milligram of immunoreactive protein, ranged from 3.1 to 5.8 units/mg. This compares favorably with DBH
in a chromaffin granule lysate from pheochromocytoma, 3.8 units/mg, as well as normal
human adrenal medulla, 4.1 units/mg. Plasma DBH was further separated into enzymatically active tetrameric and dimeric fractions. The homospecific activity of the
predominant tetrameric fraction from pooled plasma was about 20% greater than the
dimeric enzyme. The results of this study are compatible with the conclusion that various
forms of soluble human DBH are immunologically indistinguishable by homologous
radioimmunoassay. Comparison of the enzymatic and immunoreactive levels of circulating
DBH, on the other hand, may be altered by structural differences between the multiple
forms of the plasma enzyme.
Note:
ACKNOWLEDGMENTS
The authors wish to thank Dr. Richard A. Stone for the inspiration
to initiate this study, Ms. Marta Zekan for her unexcelled typing skills,
Michael Alford for assistance in computerizing the data analysis, and
Annie Chen for technical assistance.